Conference Speaker - Professor Ronald Davis
#IIMEC15: A 2020 VISION for ME
Invest in ME Research is pleased to announce that Professor Ron Davis will once again be returning to the Invest in ME Research Conference Week and will be speaking at the IIMEC15 Conference in London on 30th May 2020.
Professor Davis will also be participating in the 2-day Biomedical Research into ME Colloquium 10 which precedes the public conference day.
More details will be added as we publish the agenda.
Professor Ron Davis
Director Stanford Genome Technology Center, Palo Alto, California, USA
Professor Davis does cutting edge, innovative, interdisciplinary research and technology development on cancer, immunology,
genetics, infectious disease, novel drug development, and nanofabrication of diagnostic instrumentation. In trying to understand CFS, he has read the
literature, consulted with leading specialists, attended scientific meetings and thought extensively about how he could apply his expertise to help find a molecular diagnosis,
treatment and cure (source).
His expertise and reputation make him a uniquely qualified scientist to take on ME.
From "The Atlantic - Who Will Tomorrow's Historians Consider Today's Greatest Inventors?"
A substantial number of the major genetic advances of the past 20 years can be traced back to Davis in some way. He was one of the first scientists to begin mapping and cloning DNA, in the 1960s, and his biotech methods have proved pivotal to the Human Genome Project and the ongoing pursuit of genetically targeted medical treatments. “He’s not just a one-hit wonder,” says Church. “He’s a frequent provider of disruptive core technologies.”
We look forward to welcoming Professor Davis to London and joining the other international experts present to work toward better understanding and more collaboration in research into ME.
Other Links
- Stanford Genome Technology Center
- Ron Davis named one of today's greatest inventors
- The Chronic Fatigue Syndrome Research Center (CFSRC)
Professor of Biochemistry and Genetics at the Stanford School of Medicine in Stanford, California, USA
Ronald W. Davis, Ph.D., is a Professor of Biochemistry and Genetics at the Stanford School of Medicine in Stanford, California.
He is a world leader in the development of biotechnology, especially the development of recombinant DNA and genomic methodologies and their application to biological systems.
At Stanford University, where he is Director of the Stanford Genome Technology Center, Dr. Davis focuses on the interface of nano-fabricated solid state devices and biological systems.
He and his research team also develop novel technologies for the genetic, genomic, and molecular analysis of a wide range of model organisms as well as humans.
The team's focus on practical application of these technologies is setting the standard for clinical genomics.
